Global Manufacturing Powerhouse Sentiss operates state-of-the-art sterile manufacturing facilities in India and Switzerland, plus an FDA-approved US facility acquired through Akorn AG, enabling end-to-end ophthalmic fill-finish and contract manufacturing for US, EU, and other markets.

Market Leadership Ophthalmics As the largest ophthalmic company in Russia with a growing global footprint across USA, Europe, Dubai, and Central Asia, Sentiss offers partners access to established distribution channels and a competitive position in a high-demand eye care segment.

R&D and Partnerships With a modern R&D center focused on generic and innovative eye care, Sentiss is well positioned for co-development, technology transfer, and in-licensing/out-licensing partnerships to accelerate new products.

Scale and Capacity Revenue in the $1B-$10B range signals substantial production capacity and the ability to support high-volume supply contracts, exclusive distribution deals, and long-term collaborations.

ESG and Talent Award-winning CSR credentials and Great Place to Work certification reflect a stable, trusted workforce and responsible practices that reduce supply risk and bolster partner relationships.